Medifast (MED) Income from Continuing Operations (2010 - 2026)

Medifast has reported Income from Continuing Operations for 17 years, with the latest figure at 2122000.0 in Q1 2026.

• For the quarter ending Q1 2026, Income from Continuing Operations fell 174.16% year-over-year to 2122000.0; the trailing twelve-month figure through Mar 2026 stood at 19990000.0 (down 184.92% YoY), and the FY2025 full-year result was 18639000.0, down 991.39% from the prior year.
• Income from Continuing Operations for Q1 2026 stood at 2122000.0, up from 18086000.0 in the prior quarter.
• The five-year high for Income from Continuing Operations was 41781000.0 in Q1 2022, with the low at 18086000.0 in Q4 2025.
• Historically, Income from Continuing Operations has averaged 13191764.71 across 5 years, with a median of 6035000.0 in 2023.
• The largest YoY upside for Income from Continuing Operations was 130.37% in 2025 against a maximum downside of 2421.69% in 2025.
• Medifast's Income from Continuing Operations stood at 26518000.0 in 2022, then tumbled by 77.24% to 6035000.0 in 2023, then plunged by 87.09% to 779000.0 in 2024, then slumped by 2421.69% to 18086000.0 in 2025, then jumped by 88.27% to 2122000.0 in 2026.
• The last three Income from Continuing Operations figures came in at 2122000.0 (Q1 2026), 18086000.0 (Q4 2025), and 2257000.0 (Q3 2025), per Business Quant data.